Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women

被引:25
作者
Angeja, BG
Shlipak, MG
Go, AS
Johnston, SC
Frederick, PD
Canto, JG
Barron, HV
Grady, D
机构
[1] Univ Calif San Francisco, Div Cardiol, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA
[3] Vet Affairs Med Ctr, Gen Internal Med Sect, San Francisco, CA 94121 USA
[4] Kaiser Permanente No Calif Div Res, Oakland, CA USA
[5] Ovat Res Grp, Chicago, IL USA
[6] Univ Alabama, Med Ctr, Birmingham, AL 35294 USA
[7] Genentech Inc, S San Francisco, CA 94080 USA
关键词
D O I
10.1016/S0735-1097(01)01551-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives We examined the association of hormone therapy (HRT) with hemorrhagic and ischemic stroke among postmenopausal women with acute myocardial infarction (AMI). Background Hemorrhagic and ischemic strokes are common complications of AML and women are at increased risk for hemorrhagic stroke after thrombolytic therapy. This risk may be related to female hormones. Methods Using data from the National Registry of Myocardial Infarction-3, we studied 114,724 women age 55 years or older admitted to the hospital for AMI, of whom 7,353 reported HRT use on admission. We determined rates of in-hospital hemorrhagic and ischemic stroke stratified by HRT use and estimated the independent association of HRT with each stroke type using multivariable logistic regression. Results The HRT users were younger than non-users, had fewer risk factors for stroke including diabetes and prior stroke, and received more pharmacologic and invasive therapy including cardiac catheterization. A total of 2,152 (1.9%) in-hospital strokes occurred, with 442 (0.4%) hemorrhagic, 1,017 (0.9%) ischemic and 693 (0.6%) unspecified. Among HRT users and non-users, the rates of hemorrhagic stroke (0.40% vs. 0.42%, p=1.00) and ischemic stroke (0.80% vs. 0.96%, p=0.11) were similar. Among 13,328 women who received thrombolytic therapy, the rate of hemorrhagic stroke was not significantly different for users and non-users (1.6% vs. 2.1%, p=0.22). After adjustment for baseline, and treatment differences, HRT was not associated with hemorrhagic (odds ratio [OR], 0.88; 95% confidence intervals [CI], 0.58 to 1.35) or ischemic stroke (OR, 0.89; CI, 0.66 to 1.18). Conclusions Acute myocardial infarction is a high-risk setting for stroke among postmenopausal women, but HRT does not appear to modify that risk. Clinicians should not alter their approach; to thrombolytic therapy based on HRT use. (J Am Coll Cardiol 2001;38:1297-301) (C) 2001 by the American College of Cardiology.
引用
收藏
页码:1297 / 1301
页数:5
相关论文
共 23 条
[1]   Death or nonfatal stroke in patients with acute myocardial infarction treated with tissue plasminogen activator [J].
Angeja, BG ;
Rundle, AC ;
Gurwitz, JH ;
Gore, JM ;
Barron, HV .
AMERICAN JOURNAL OF CARDIOLOGY, 2001, 87 (05) :627-630
[2]   Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction [J].
Berkowitz, SD ;
Granger, CB ;
Peiper, KS ;
Lee, KL ;
Gore, JM ;
Simoons, M ;
Armstrong, PW ;
Topol, EJ ;
Califf, RM .
CIRCULATION, 1997, 95 (11) :2508-2516
[3]  
D'Agostino RB, 1998, STAT MED, V17, P2265, DOI 10.1002/(SICI)1097-0258(19981015)17:19<2265::AID-SIM918>3.0.CO
[4]  
2-B
[5]   A comparison of the national registry of myocardial infarction 2 with the Cooperative Cardiovascular Project [J].
Every, NR ;
Frederick, PD ;
Robinson, M ;
Sugarman, J ;
Bowlby, L ;
Barron, HV .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 33 (07) :1886-1894
[6]   DECREASED RISK OF STROKE AMONG POSTMENOPAUSAL HORMONE USERS - RESULTS FROM A NATIONAL COHORT [J].
FINUCANE, FF ;
MADANS, JH ;
BUSH, TL ;
WOLF, PH ;
KLEINMAN, JC .
ARCHIVES OF INTERNAL MEDICINE, 1993, 153 (01) :73-79
[7]   ASSOCIATION BETWEEN INCREASED ESTROGEN STATUS AND INCREASED FIBRINOLYTIC POTENTIAL IN THE FRAMINGHAM OFFSPRING STUDY [J].
GEBARA, OCE ;
MITTLEMAN, MA ;
SUTHERLAND, P ;
LIPINSKA, I ;
MATHENEY, T ;
XU, P ;
WELTY, FK ;
WILSON, PWF ;
LEVY, D ;
MULLER, JE ;
TOFLER, GH .
CIRCULATION, 1995, 91 (07) :1952-1958
[8]   Ischemic stroke risk with oral contraceptives - A meta-analysis [J].
Gillum, LA ;
Mamidipudi, SK ;
Johnston, SC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2000, 284 (01) :72-78
[9]   STROKE AFTER THROMBOLYSIS - MORTALITY AND FUNCTIONAL OUTCOMES IN THE GUSTO-I TRIAL [J].
GORE, JM ;
GRANGER, CB ;
SIMOONS, ML ;
SLOAN, MA ;
WEAVER, D ;
WHITE, HD ;
BARBASH, GI ;
VANDEWERF, F ;
AYLWARD, PE ;
TOPOL, EJ ;
CALIFF, RM .
CIRCULATION, 1995, 92 (10) :2811-2818
[10]   Postmenopausal hormone therapy increases risk for venous thromboembolic disease - The heart and estrogen/progestin replacement study [J].
Grady, D ;
Wenger, NK ;
Herrington, D ;
Khan, S ;
Furberg, C ;
Hunninghake, D ;
Vittinghoff, E ;
Hulley, S .
ANNALS OF INTERNAL MEDICINE, 2000, 132 (09) :689-+